ArticleFrontiers in aging neuroscience2026
Systems-level molecular and immunological evidence identifies Th17/Treg modulation as a key mechanism of CRSJ's neuroprotection in Parkinson's disease.
Xun Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.